Amal A. Alsubaiei
Amal A. Alsubaiei publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism, on topics such as Atrial Fibrillation Management and Outcomes, Acute Myocardial Infarction Research and Chemotherapy-induced cardiotoxicity and mitigation.
- World rank
- #3,912,233 of 7,710,434 ranked researchers
- Rank in Kuwait
- #1,077 of 2,469
- Works
- 15
- Citations
- 5
- Citations per work
- 0.3
What does Amal A. Alsubaiei research?
Amal A. Alsubaiei's work is mostly in Medicine (84%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1384.4%
- Medicine1384.4%
- Everything else215.6%
- 1Cardiology and Cardiovascular Medicine49% of their works
- 2Surgery13% of their works
- 3Endocrinology, Diabetes and Metabolism7% of their works
- 4Pulmonary and Respiratory Medicine7% of their works
- 5Oncology4% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Chemotherapy-induced cardiotoxicity and mitigation
- Lipoproteins and Cardiovascular Health
- Blood Pressure and Hypertension Studies
- Lipid metabolism and disorders
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cancer, Lipids, and Metabolism
Which keywords describe Amal A. Alsubaiei's research?
The keywords of their largest research topics: Cardiovascular Disease, Guidelines, Anticoagulant Therapy, Atherosclerosis, Atrial Fibrillation, Metabolic Syndrome, Statins and Acute Coronary Syndromes.
- Lipid Metabolism
- Lipoprotein Lipase
- Hypertension
- Blood Pressure
- Myocardial Infarction
- Cholesterol-lowering
- Cardiovascular Disease Prevention
- Acute Coronary Syndromes
- Metabolic Syndrome
- Atherosclerosis
- Guidelines
- Cardiovascular Disease
- Anticoagulant Therapy
- Atrial Fibrillation
- Statins
- Anthracyclines
- Cholesterol
- Doxorubicin
- ANGPTL3
- Diabetes
- Insulin Resistance
- Fatty Acid Synthase
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Cardiovascular Disease73 topics
- Guidelines72 topics
- Anticoagulant Therapy41 topic
- Atherosclerosis42 topics
- Atrial Fibrillation41 topic
- Metabolic Syndrome42 topics
- Statins42 topics
- Acute Coronary Syndromes31 topic
- Anthracyclines31 topic
- Cardiovascular Disease Prevention31 topic
- Cholesterol32 topics
- Cholesterol-lowering31 topic
- Doxorubicin31 topic
- Myocardial Infarction31 topic
- ANGPTL321 topic
- Blood Pressure21 topic
- Diabetes21 topic
- Hypertension21 topic
- Insulin Resistance21 topic
- Lipoprotein Lipase21 topic
- Fatty Acid Synthase11 topic
- Lipid Metabolism11 topic
Where does Amal A. Alsubaiei work?
Amal A. Alsubaiei's main affiliation in the publication record is Kuwait Institute for Medical Specialization, Kuwait.
How many publications and citations does Amal A. Alsubaiei have?
OpenAlex counts 15 works and 5 citations for Amal A. Alsubaiei, an h-index of 1, ranking #3,912,233 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Amal A. Alsubaiei. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.